SRB Corp’s Medtronic MDT Stock Holding History

SRB Corp’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,296	Closed	-$346K	–	115
2023 Q1	$346K	Sell	4,296 -1,293	-23%	-$105K	0.02%	86
2022 Q4	$435K	Buy	5,589 +1,039	+23%	+$84.2K	0.03%	73
2022 Q3	$368K	Buy	+4,550	New	+$409K	0.03%	76
2018 Q2	–	Sell	-2,559	Closed	-$205K	–	185
2018 Q1	$205K	Buy	+2,559	New	+$211K	0.03%	72

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SRB Corp's MDT Position: Q2 2023 in Review

SRB Corp sold out of Medtronic (MDT) in Q2 2023, closing a stake of 4,296 shares — an estimated $346K sold.

SRB Corp first reported a position in MDT in Q1 2018 and held it in 4 quarters. The position peaked at $435K in Q4 2022. 2,056 funds tracked by Wall St. Rank hold MDT as of Q2 2023.

SRB Corp reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
SRB Corp sold 4,296 Medtronic shares in Q2 2023, an estimated $346K.
SRB Corp first reported a position in Medtronic in Q1 2018 and held it in 4 quarters.
SRB Corp's Medtronic position peaked at $435K in Q4 2022.
2,056 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.

Based on SRB Corp's 13F filing for Q2 2023, filed 14 Aug 2023.